Highly Chemoselective Trichloroacetimidate-Mediated Alkylation of Ascomycin: A Convergent, Practical Synthesis of the Immunosuppressant L-733,725.

doi:10.1021/JO981805G

Paper

Highly Chemoselective Trichloroacetimidate-Mediated Alkylation of Ascomycin: A Convergent, Practical Synthesis of the Immunosuppressant L-733,725.

Published Mar 19, 1999 · Z. Song, A. Demarco, Mangzhu Zhao

The Journal of organic chemistry

Q2 SJR score

8

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

L-733,725, a new immunosuppressant drug candidate, was prepared by a highly chemoselective alkylation of the macrolide ascomycin at the C32 hydroxy position with the imidazolyl trichloroacetimidate 16. The trichloroacetimidate-activated side chain 16 was prepared by an efficient four-step sequence in 42% overall yield. The high chemoselectivity in the alkylation of the C32 hydroxy group of the unprotected ascomycin was the result of the synergetic effects of the electron-donating protecting group on the imidazole 16, the polar, moderately basic solvent, and the strong acid catalyst. N,N-Dimethylpivalamide mixed with acetonitrile was found to be the best solvent and trifluromethanesulfonic acid the best catalyst. This synthesis coupled with a resin column purification of L-733,725 followed by crystallization of its tartrate salt has been used to make multi-kilogram quantities of the bulk drug with consistent and high purity.

Study Snapshot

L-733,725 is a promising immunosuppressant drug candidate prepared by a highly chemoselective alkylation of ascomycin at the C32 hydroxy position, with high purity and consistent production.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Highly Chemoselective Trichloroacetimidate-Mediated Alkylation of Ascomycin: A Convergent, Practical Synthesis of the Immunosuppressant L-733,725.

Sign up to use Study Snapshot

References

Citations

4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator

12g, a dual c-Met and P-gp/MRP inhibitor, shows potential as a promising lead compound for developing a new generation of anticancer agents.

Synthesis of a new family of acyclic nucleoside phosphonates, analogues of TPases transition states.

"PHEEPA" compounds show potential as antiviral agents or transition state analogues of nucleoside phosphorylases, offering potential for antiviral and transition state studies.

Carbon‐14 labeling of a potential new immunoregulant agent

Carbon-14 labeling of the ascomycin analog 1 shows potential as an immunosuppressant agent for both animal and human drug metabolism studies.

Chemistry of the immunomodulatory macrolide ascomycin and related analogues.

Pimecrolimus cream and tacrolimus ointment are effective and safe alternatives to corticosteroids for treating inflammatory skin diseases like atopic dermatitis.